In Part 1 of this series we covered some basic definitions and reviewe...

Many emerging cell and gene therapies are aimed at using cell replacem...

Outsourcing to a contract development and manufacturing organization (...

A core regenerative medicine approach is cell replacement for the repa...

In a previous post we provided an overview of induced pluripotent stem...

Developing cell and gene therapies (CGTs), from discovery to commercia...

Responsibly moving a cell or gene therapy forward as quickly as possib...

If you are looking to get a lentiviral vector (LVV) program off the gr...

Outsourcing to a contract development and manufacturing organization (...

Whether you are developing a therapeutic or an enabling technology, yo...

Viral vectors are vehicles for delivery of therapeutic DNA in cell and...